Product Reports Resources Pricing Login Book a demo

Viridos

Aviation · San Diego, United States · Founded 2005

A leader in the field of synthetic biology, advancing genomics to better life MoreLess

Viridos is a biotechnology startup that is focused on developing advanced biofuel technology to mitigate climate change. The company's primary product is algal biofuel, a renewable energy source that offers a solution for industries struggling to decarbonize. Viridos operates in the renewable energy market, specifically in the biofuel sector, serving clients across various industries that are seeking sustainable energy alternatives.

The company's business model revolves around the development and commercialization of its proprietary algal biofuel technology. It generates revenue by selling this biofuel to industries that are transitioning away from fossil fuels. Viridos has also formed a strategic partnership with ExxonMobil, a major player in the energy sector, to bring algae biofuel to the global stage. This partnership is aimed at decarbonizing heavy transportation, a sector that has traditionally been reliant on fossil fuels.

In addition to its biofuel technology, Viridos has developed a proprietary RNA replicon platform for creating innovative vaccines and therapeutics. This platform uses advanced genomics and bioengineering to selectively stimulate the immune system and deliver targeted therapies produced within the body.

The company's mission is to replace unsustainable systems with products and processes that reduce greenhouse gas emissions, ultimately contributing to a future where everyone can thrive. Every position at Viridos supports this higher purpose of mitigating climate change.

Keywords: Biotechnology, Biofuel, Algae, Renewable Energy, Climate Change Mitigation, Decarbonization, Heavy Transportation, ExxonMobil Partnership, RNA Replicon Platform, Sustainable Systems.

Company overview

Viridos company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2005
Headquarters
San Diego, United States
Employees
47
Open positions
None listed
Dealroom signal
64.5
Investment activity
1 companies · latest Jan 2013
Capital deployed
$0
Preferred round
CORPORATE SPINOUT
business modelManufacturingsectorIntellectual PropertysectorBiotechnologysectorDNAsectorAlgaesectorGenetics and genomicssectorSynthetic BiologysectorCrisprsectorBiofuelsectorGenome EngineeringsectorAlternative ProteinsectorSustainable Development GoalssectorAviation and AerospacesectorPay Per Result

Valuation & funding

Viridos funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Mar 2023 $25M $250M Breakthrough Energy Ventures · United Airlines Venture · Chevron
GRANTOther financing Apr 2022 $0 Undisclosed
EARLY VCOther financing Apr 2014 $50M $200M Lung Biotechnology
EARLY VCOther financing Feb 2013 $0 OS Fund
EARLY VCOther financing Oct 2011 $0 BP Ventures
EARLY VCOther financing Jun 2010 LifeTechnologies
EARLY VCOther financing Jun 2007 BP Ventures
SERIES AOther financing Dec 2005 Frontier Venture Capital · Biotechonomy
Showing 8 recorded eventsUnlock the complete deal history →

Growth signals

Viridos website traffic

Latest recorded traffic for Viridos is 1.6K monthly website visits, up 344.4% over the last three months. Viridos's team declined 6% over the past year.

Latest monthly visits1.6K 3-month web change+344.4% 1-year team growth-6%
Monthly website visits89 observations · Apr 2016–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Viridos compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Viridos's talent

Book a demo to see the people
Team profiled 46 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

9 investors on Viridos's cap table

Sourced from Dealroom's funding and investor records.

Series A 9 investors entered at this stage
Frontier Venture Capital
Biotechonomy
BP Ventures
LifeTechnologies
OS Fund
Lung Biotechnology
Breakthrough Energy Ventures
United Airlines Venture
Chevron

Global footprint

Where Viridos has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States96.8%
🇨🇭 Switzerland3.2%
2 countries shown

In the news

Latest news about Viridos

Recent press, funding announcements, and product moves mentioning Viridos — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Viridos

An AI-synthesized read of the highest-engagement posts about Viridos on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Viridos’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.